Efficacy of Isradipine in Early Parkinson Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Parkinson Disease
Interventions
DRUG

Isradipine

Oral capsules Isradipine IR, up to 10 mg, taken twice daily

DRUG

Placebo (for Isradipine)

Sugar Pill manufactured to look like Isradipine but has no active ingredients

Trial Locations (54)

10032

Columbia University Medical Center, New York

12208

Albany Medical College, Albany

12401

Health Quest Kingston, Kingston

14618

University of Rochester, Rochester

17033

Milton S Hershey Medical Center, Hershey

19107

University of Pennsylvania, Philadelphia

20021

Weill Medical College of Cornell University, New York

21201

University of Maryland, Baltimore

21287

Johns Hopkins University, Baltimore

22903

University of Virginia, Charlottesville

23456

Sentara Neurology Specialists, Virginia Beach

29401

Medical University of South Carolina, Charleston

30329

Emory University School of Medicine, Atlanta

33136

University of Miami, Miami

33613

University of South Florida, Tampa

35233

University of Alabama at Birmingham, Birmingham

40536

University of Kentucky Medical Center, Lexington

43221

Ohio State University, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

45267

University of Cincinnati, Cincinnati

48109

University of Michigan, Ann Arbor

48824

Michigan State University, East Lansing

53226

Medical College of Wisconsin, Milwaukee

55414

University of Minnesota, Minneapolis

55427

Struthers Parkinson's Center, Golden Valley

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University, St Louis

68198

Nebraska Medical Center, Omaha

71103

LSU Health Science Center, Shreveport

77030

University of Texas Health Science Center, Houston

80113

Rocky Mountain Movement Disorders Center, Englewood

84108

University of Utah, Salt Lake City

85315

Banner Sun Health Research Institute, Sun City

89102

University of Nevada School of Medicine, Las Vegas

92093

University of California San Diego, San Diego

92697

University of California, Irvine

92708

The Parkinsons & Movement Disorder Institute, Fountain Valley

94143

University of California, San Francisco, San Francisco

96819

Pacific Health Research & Education Institute, Honolulu

97239

Oregon Health & Science University, Portland

98034

Booth Gardner Parkinson's Care Center, Kirkland

06510

Institute of Neurodegenerative Disorders, New Haven

02114

Massachusetts General Hospital, Boston

02118

Boston University Medical Center, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

07901

Atlantic Neuroscience Institute, Summit

T2N 4Z6

University of Calgary, Calgary

t6g 2g3

University of Alberta Hospital, Edmonton

K1Y 4E9

Ottawa Hospital Civic Site, Ottawa

m3b 2s7

The Centre for Addiction and Mental Health, Toronto

M5T 2S8

Toronto Western Hospital, University Health Network, Toronto

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

G1J 1Z4

Centre Hospitalier Affilie, Québec

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

collaborator

The Parkinson Study Group

NETWORK

lead

University of Rochester

OTHER

NCT02168842 - Efficacy of Isradipine in Early Parkinson Disease | Biotech Hunter | Biotech Hunter